Quest Diagnostics Incorporated (DGX) Shares are Down -2.27%

Quest Diagnostics Incorporated (DGX) : During the past 4 weeks, traders have been relatively bearish on Quest Diagnostics Incorporated (DGX), hence the stock is down -3.71% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.63% relative to the S&P 500. The 4-week change in the price of the stock is -3.91% and the stock has fallen -2.27% in the past 1 week.

Company shares have received an average consensus rating of Hold for the current week The stock has recorded a twenty day Moving Average of 2.64% and the fifty day Moving Average is 0.08%. Quest Diagnostics Inc. is up 8% in the last three month period. Year-to-Date the stock performance stands at 18.53%.

Quest Diagnostics Incorporated (DGX) has been rated by 10 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $90 and the lowest price target forecast is $70. The average forecast of all the analysts is $79.9 and the expected standard deviation is $6.42.


Quest Diagnostics Incorporated (NYSE:DGX): On Fridays trading session , Opening price of the stock was $83.43 with an intraday high of $83.77. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $82.66. However, the stock managed to close at $82.98, a loss of 0.23% for the day. On the previous day, the stock had closed at $83.17. The total traded volume of the day was 1,614,615 shares.

Quest Diagnostics Incorporated is a provider of diagnostic testing information services. The Company consists of two businesses: Diagnostic Information Services and Diagnostic Solutions. Diagnostic Information Services business, consists of two parts, develops and delivers diagnostic testing, information and services to patients, physicians, health plans, hospitals, accountable care organizations (ACOs), integrated delivery networks (IDNs), other commercial laboratories, patients and other customers. Diagnostics Information Services business also provides diagnostic information services, which includes providing clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services and drugs-of-abuse testing. Diagnostic Solutions includes the Companys other businesses, including central laboratory testing for pharmaceutical and medical device clinical trials, risk assessment services, diagnostic products and healthcare information technology.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.